Listed
Sai Life Sciences Limited IPO
Sai Life Sciences Limited is a leading Contract Research, Development, and Manufacturing Organization (CRDMO) serving global pharmaceutical and biotech companies. Established in 1999, the company specializes in drug discovery, process development, and commercial manufacturing of Active Pharmaceutical Ingredients (APIs). It has a strong global presence with operations in India, the US, and the UK. Sai Life Sciences recently went public in December 2024, raising ₹3,042.62 crore to fund expansion and debt repayment.
Min Investment
₹14,823
Lot Size
27 Shares
Price Range
₹522.0 - 549.0
Issue Size (₹ Cr.)
₹549.0
IPO Type
Mainboard
Key Metrics
Face Value
₹ 1 Per share
GMP
Subscription
10.27x
EPS
₹ 2.69
P/E Ratio
203.82 x
RoNW
8.13%
ROE
11.79%
Debt to Equity (₹ Cr.)
0.95
Timeline
IPO Opened11/12/2024Wednesday
IPO Closed13/12/2024Friday
Allotted16/12/2024Monday
Refunded17/12/2024Tuesday
Listed18/12/2024Wednesday
Strengths
- Comprehensive Services: Sai Life Sciences offers end-to-end drug discovery, development, and manufacturing solutions, ensuring faster time-to-market.
- Strong Financials & Quality Compliance: The company maintains steady revenue growth and adheres to global quality standards like FDA and ICH.
- Global Presence & Sustainability Focus: With 300+ pharma clients worldwide, Sai Life Sciences emphasizes eco-friendly operations and long-term growth.
Weaknesses
- High Client Concentration: A significant portion of revenue comes from a few key clients, making the company vulnerable to contract losses.
- Regulatory Compliance Risks: Operating in the pharma sector requires strict adherence to global standards, with any lapse leading to fines or reputational damage.
- High Operational Costs: Heavy investments in technology and infrastructure increase expenses, impacting overall profitability.
- Capacity Constraints: Running at nearly full capacity may limit the company's ability to scale production and meet growing demand.
Financials
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets (₹Cr) | 2,476.78 | 2,275.14 | 2,186.65 | 2,164.23 |
| Revenue (₹Cr) | 693.35 | 1,494.27 | 1,245.11 | 897.74 |
| Profit After Tax (₹Cr) | 28.01 | 82.81 | 9.99 | 6.23 |
| Net Worth (₹Cr) | 1,044.75 | 974.34 | 887.29 | 877.76 |
| Reserves and Surplus (₹Cr) | 1,025.44 | 953.99 | 867.43 | 859.17 |
| Total Borrowing (₹Cr) | 764.49 | 710.16 | 699.23 | 751.32 |
Subscription Details
IPO Bidding Live Updates from BSE, NSE
| Day | # of Share Offered | Number of Lots Offered | 11th Dec 2024 19:04 | 12th Dec 2024 19:04 | 13th Dec 2024 18:21 |
|---|---|---|---|---|---|
| QIB | 1,10,84,225 | 410527 | 2.52x | 3.20x | 29.78x |
| NII | 83,13,168 | 307895 | 0.16x | 0.60x | 4.99x |
| S-NII | 27,71,056 | 102632 | 0.17x | 0.63x | 2.78x |
| B-NII | 55,42,113 | 205263 | 0.15x | 0.59x | 6.10x |
| RII | 1,93,97,392 | 718422 | 0.19x | 0.43x | 1.39x |
| Total | 3,87,94,785 | 1436844 | 0.85x | 1.26x | 10.27x |
IPO Bidding Live Number of Shares by Category
| Category | Number of Shares offered | Number of Shares Bid | Bid Amount(Rs Cr) | ||
|---|---|---|---|---|---|
| QIB | 1,10,84,225 | 33,01,25,058 | 18,123.87 | ||
| NII | 83,13,168 | 4,15,22,058 | 2,279.56 | ||
| Small NII | 27,71,056 | 77,08,365 | 423.19 | ||
| Big NII | 55,42,113 | 3,38,13,693 | 1,856.37 | ||
| RII | 1,93,97,392 | 2,69,12,493 | 1,477.50 | ||
| Total | 3,87,94,785 | 39,85,59,609 | 21,880.92 |
Company Details
- Plot No. DS-7, IKP Knowledge Park Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078
+91 40 6815 6000
- investors@sailife.com
- https://www.sailife.com/
Registrar Details
- KFintech, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Gachibowli, Hyderabad, Telangana India - 500 032.
04067162222, 04079611000
- sailifesciences.ipo@kfintech.com
- https://kosmic.kfintech.com/ipostatus/
